Advanced Melanoma & Immunotherapy: Leta Brown’s Story Leta Brown of Maryland was only 43 when she was diagnosed with advanced metastatic melanoma in 2013. She sought treatment at MedStar Georgetown University Hospital where she enrolled in a clinical trial of two immunotherapy agents, nivolumab (Opdivo) and ipilimumab (Yervoy) through Georgetown University's Lombardi Comprehensive Cancer Center. Within weeks her cancer began to shrink. Today she is cancer free. Leta's treatment regimen for advanced melanoma is now FDA approved. To make an appointment or learn more, call 1-888-666-3432 or visit